<DOC>
	<DOCNO>NCT00930007</DOCNO>
	<brief_summary>The purpose study determine whether sleep-wake change luteinizing hormone pulse frequency different early pubertal girl high testosterone level compare early pubertal girl normal testosterone level .</brief_summary>
	<brief_title>Sleep-wake Changes Luteinizing Hormone Frequency Pubertal Girls With Without High Testosterone</brief_title>
	<detailed_description>During early puberty , luteinizing hormone ( LH ) pulse frequency normally increase sleep . In contrast , preliminary data suggest obese girl ( high testosterone level general ) demonstrate low LH frequency day night early puberty ; mid puberty rapidly transition high LH frequency day night . We hypothesize early pubertal girl high testosterone level , overnight increase LH frequency less prominent observe early pubertal girl normal testosterone level . We assess use frequent sample protocol assessment LH pulse frequency ( sample occur awake asleep ) early pubertal girl without high testosterone level . Sleep formally evaluate .</detailed_description>
	<mesh_term>Hyperandrogenism</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<criteria>Early midpubertal girl ( late Tanner 1 [ i.e. , estradiol &gt; 20 pg/ml ] Tanner 3 ) Premenarcheal Approximate age , 815 year BMIforage &lt; 5th percentile Inability comprehend do study do Being study GnRH pulse regulation adolescent girl without HA , boys excluded Obesity associate diagnose ( genetic ) syndrome ( e.g. , PraderWilli syndrome , leptin deficiency ) , obesity relate medication ( e.g. , glucocorticoid ) , etc . Pregnancy lactation Virilization Total testosterone &gt; 150 ng/dl ( confirmed repeat ) DHEAS &gt; upper limit ageappropriate normal range ( confirmed repeat ) ( mild elevation may see adolescent HA , elevation &lt; 1.5 time ageappropriate upper limit normal accepted girl ) Follicular phase 17hydroxyprogesterone &gt; 250 ng/dl ( girls &lt; 12 year old ) &gt; 300 ng/dl ( girls 12 old ) ( confirm repeat ) , suggest possibility congenital adrenal hyperplasia . NOTE : If elevate follicular 17hydroxyprogesterone confirm repeat testing , ACTH stimulate 17hydroxyprogesterone &lt; 1000 ng/dl require study participation History premature adrenarche ( i.e. , appearance pubic and/or axillary hair age 8 ) A previous diagnosis diabetes Fasting glucose â‰¥ 126 mg/dl , hemoglobin A1c &gt; 6.5 % ( confirmed repeat ) Abnormal TSH ( confirm repeat ) ( subject adequately treat hypothyroidism , reflect normal TSH value , exclude ) Abnormal prolactin ( confirmed repeat ) ( mild elevation may see HA girl , elevation &lt; 1.5 time upper limit normal accept group ) Evidence Cushing 's syndrome history physical exam ( e.g. , history impaired growth child , stria ) Hematocrit &lt; 36 % hemoglobin &lt; 12 g/dl ( confirmed repeat ) Significant history cardiac pulmonary dysfunction ( e.g. , know suspect congestive heart failure ; asthma require intermittent systemic corticosteroid ; etc . ) Persistent liver test abnormality ( confirm repeat ) , exception mild bilirubin elevation accept set know Gilbert 's syndrome Persistently abnormal sodium , potassium , elevate creatinine concentration ( confirmed repeat ) Bicarbonate concentration &lt; 20 &gt; 30 ( confirm repeat ) No medication know affect reproductive system , glucose metabolism , lipid metabolism , blood pressure take 3 month prior first inpatient GCRC study ( 2 month prior screen ) Such medication include oral contraceptive pill , progestin , metformin , glucocorticoid , psychotropics , sympathomimetics/stimulants ( e.g. , methylphenidate ) Patients take restricted medication exclude unless write permission ( subject discontinue medication ) receive subject 's physician Weight &lt; 22 kg absolute exclusion criterion ( ensure safe blood withdrawal )</criteria>
	<gender>Female</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>15 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Luteinizing hormone</keyword>
	<keyword>Puberty</keyword>
</DOC>